There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Insmed (INSM – Research Report), Agilon Health (AGL – Research Report) and Blueprint Medicines (BPMC – Research Report) with bullish sentiments.
Insmed (INSM)
Wells Fargo analyst Tiago Fauth maintained a Buy rating on Insmed on January 5 and set a price target of $55.00. The company’s shares closed last Friday at $29.35, close to its 52-week high of $32.00.
According to TipRanks.com, Fauth is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Insmed is a Strong Buy with an average price target of $44.10, which is a 52.8% upside from current levels. In a report issued on January 1, Leerink Partners also maintained a Buy rating on the stock with a $50.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Agilon Health (AGL)
Wells Fargo analyst Steve Baxter maintained a Buy rating on Agilon Health on January 5 and set a price target of $16.00. The company’s shares closed last Friday at $8.63, close to its 52-week low of $7.59.
According to TipRanks.com, Baxter is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Agilon Health with a $16.15 average price target, a 108.4% upside from current levels. In a report issued on January 2, Benchmark Co. also maintained a Buy rating on the stock with a $22.00 price target.
Blueprint Medicines (BPMC)
Wells Fargo analyst Derek Archila maintained a Buy rating on Blueprint Medicines on January 5 and set a price target of $115.00. The company’s shares closed last Friday at $82.97.
According to TipRanks.com, Archila is a 4-star analyst with an average return of
Currently, the analyst consensus on Blueprint Medicines is a Moderate Buy with an average price target of $80.93, a -4.1% downside from current levels. In a report issued on January 2, Guggenheim also maintained a Buy rating on the stock with a $90.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on INSM:
